Tigecycline Activity Against Isolates from Medical Centers Located in China, Hong Kong and Taiwan (2006): A SENTRY Antimicrobial Surveillance Program Report

被引：0

作者：

Chen, M. ^{[1
]}

Bell, J. M. ^{[2
]}

Turnidge, J. D. ^{[2
]}

Jones, R. N. ^{[3
]}

Dowzicky, M. J. ^{[4
]}

机构：

[1] Peking Union Med Coll, Beijing 100021, Peoples R China

[2] Womens & Childrens Hosp, Adelaide, SA, Australia

[3] JMI Labs, N Liberty, IA USA

[4] Wyeth Pharmaceut, Collegeville, PA USA

来源：

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES | 2008年 / 12卷

关键词：

D O I：

10.1016/j.ijid.2008.05.1082

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

引用

页码：E411 / E411

页数：1

共 50 条

[21] Oritavancin in vitro activity against Gram-positive organisms from European medical centers: a 10-year longitudinal overview from the SENTRY Antimicrobial Surveillance Program (2010-2019)
Pfaller, M. A.
Mendes, R. E.
Sader, H. S.
Castanheira, M.
Carvalhaes, C. G.
JOURNAL OF CHEMOTHERAPY, 2023, 35 (08) : 689 - 699
[22] Antimicrobial activity of tigecycline against community-acquired methicillin-resistant Staphylococcus aureus isolates recovered from North American medical centers
Mendes, Rodrigo E.
Sader, Helio S.
Deshpande, Lalitagauri
Jones, Ronald N.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2008, 60 (04) : 433 - 436
[23] Antimicrobial activities of tigecycline and other broad-spectrum antimicrobials tested against serine carbapenemase- and metallo-β-lactamase-producing enterobactefiaceae:: Report from the SENTRY antimicrobial surveillance program
Castanheira, Mariana
Sader, Helio S.
Deshpande, Lalitagauri M.
Fritsche, Thomas R.
Jones, Ronald N.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2008, 52 (02) : 570 - 573
[24] INVITRO COMPARATIVE ANTIMICROBIAL ACTIVITY OF CEFPIMIZOLE AGAINST CLINICAL ISOLATES FROM 5 MEDICAL CENTERS
JONES, RN
AYERS, LW
GAVAN, TL
GERLACH, EH
SOMMERS, HM
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1985, 27 (06) : 982 - 984
[25] In Vitro Activity of Cefiderocol against US and European Gram-Negative Clinical Isolates Collected in 2020 as Part of the SENTRY Antimicrobial Surveillance Program
Shortridge, Dee
Streit, Jennifer M.
Mendes, Rodrigo
Castanheira, Mariana
MICROBIOLOGY SPECTRUM, 2022, 10 (02):
[26] In vitro activity of selected cephalosporins and erythromycin against staphylococci and pneumococci isolated at 38 North American medical centers participating in the SENTRY Antimicrobial Surveillance Program, 1997-1998
Jones, RN
Jenkins, SG
Hoban, DJ
Pfaller, MA
Ramphal, R
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2000, 37 (02) : 93 - 98
[27] Antimicrobial activity of broad-spectrum agents tested against Gramnegative bacilli resistant to ceftazidime: report from the SENTRY Antimicrobial Surveillance Program (North America, 2001)
Jones, RN
Varnam, DJ
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2002, 44 (04) : 379 - 382
[28] Potency and spectrum trends for cefepime tested against 65,746 clinical bacterial isolates collected in North American medical centers: Results from the SENTRY Antimicrobial Surveillance Program (1998-2003)
Sader, HS
Fritsche, TR
Jones, RN
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2005, 52 (03) : 265 - 273
[29] Activity of linezolid against 3,251 strains of uncommonly isolated gram-positive organisms: Report from the SENTRY antimicrobial surveillance program
Jones, Ronald N.
Stilwell, Matthew G.
Hogan, Patricia A.
Sheehan, Daniel J.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2007, 51 (04) : 1491 - 1493
[30] Comparisons of parenteral broad-spectrum cephalosporins tested against bacterial isolates from pediatric patients: report from the SENTRY Antimicrobial Surveillance Program (1998-2004)
Jones, Ronald N.
Sader, Helio S.
Fritsche, Thomas R.
Pottumarthy, Sudha
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2007, 57 (01) : 109 - 116

← 1 2 3 4 5 →